Pelvic Inflammatory Disease - Cause
PID, sexually transmitted disease (STD), and bacterial vaginosis
Pelvic inflammatory disease (PID) is
usually caused by a
sexually transmitted disease (STD) that infects the
cervix, which connects the upper vagina to the uterus.
When the cervix is infected with an STD, it becomes easier for other bacteria
present in the vagina to get into and infect the uterus and fallopian tubes.
PID can also develop as a result of
bacterial vaginosis (BV), which is a drop in the
vagina's "good" organisms and an increase in its potentially "bad" organisms.
When this happens and the problem organisms spread into the uterus and
fallopian tubes, PID can result. (BV is not sexually transmitted.) See a
picture of the
female pelvic organs
.
The most common causes of PID are:
- Gonorrhea, a sexually transmitted bacterial infection.
- Chlamydia, a sexually transmitted bacterial infection. PID caused by chlamydia is most common among teenagers and young adult women.
PID caused by chlamydia may have milder symptoms or no symptoms (compared with PID caused by gonorrhea), which can delay diagnosis.
Practicing safe sex by using condoms prevents STD infection. This greatly lowers PID risk. For more information, see the Prevention section of this topic.
For more information, see the topics Gonorrhea, Chlamydia, and Bacterial Vaginosis.
PID and intrauterine devices (IUDs)
Women who have an intrauterine device (IUD) inserted for birth control have a higher risk of getting PID in the first month after insertion, especially if bacterial vaginosis or an STD is present at the cervix at the time of insertion. The insertion procedure may transfer bacteria from the vagina or cervix to the uterus. Your risk of infection can be reduced if:
- You are tested and treated for STDs and bacterial vaginosis (if detected) before IUD insertion.
- The insertion is done carefully to minimize the chance of infection (clean technique).
PID that spreads to abdominal organs
PID can spread to other abdominal organs, either from the pelvic organs through the lymphatic system or from the far ends of the fallopian tubes. This may be more common in women who have just:
- Given birth.
- Had uterine tests or
other procedures, such as:
- Taking a tissue sample of the uterine lining (endometrial biopsy).
- Scraping the lining of the uterus (dilation and curettage, or D&C).
- Examining the uterus or fallopian tubes with a lighted viewing tube (hysteroscopy or hysterosalpingogram).
- Had an abortion.
WebMD Medical Reference from Healthwise
Pelvic Inflammatory Disease Topics
ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:
- · having a strong need to go to the bathroom right away (also called "urgency")
- · leaks or wetting accidents (also called "urinary incontinence")
- · having to go to the bathroom too often (also called "urinary frequency")
IMPORTANT SAFETY INFORMATION
You should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


